A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer - Concepedia

Concepedia

Publication | Closed Access

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

205

Citations

23

References

2008

Year

Harold J. Burstein, Anna Maria Storniolo, Sandra Franco, John Forster, S. Stein, S. D. Rubin, Vanessa Salazar, Kimberly Blackwell

Annals of Oncology

Metastatic Breast CancerBreast OncologyMedicineLapatinib MonotherapyPathologyPhase Ii StudyBreast CancerCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1